Literature DB >> 22300371

Role of lentivirus-mediated overexpression of programmed death-ligand 1 on corneal allograft survival.

M Nosov1, M Wilk, M Morcos, M Cregg, L O'Flynn, O Treacy, T Ritter.   

Abstract

To investigate the role of lentivirus-mediated overexpression of programmed death-ligand 1 (PD-L1) on rat corneal allograft survival. A fully allogeneic rat cornea transplant model was used for in vivo studies. Lentiviral (LV) vectors are efficient tools for ex vivo genetic modification of cultured corneas. LV vector encoding for PD-L1 (LV.PD-L1) and LV vector encoding for eGFP (LV.eGFP, as control) were constructed and tested. PD-L1 or eGFP expression was increased on corneal cells upon LV.PD-L1 and LV.eGFP transduction, respectively. Both allogeneic controls and allogeneic LV.eGFP transduced corneas were uniformly rejected (MST: 13.8 ± 1.7 days and 12.3 ± 1.9 days, respectively). In contrast, allogeneic LV.PD-L1 transduced corneas showed a high percentage (83%) of graft survival (MST > 30 days, n = 5, 15 days, n = 1). Graft opacity of PD-L1 transduced corneas was present but was significantly reduced compared to control or eGFP expressing corneas. Flow cytometric analysis revealed that percentages of CD3(+) CD8(+) CD161(+) and CD3(+) CD8(+) CD161(-) lymphocytes were decreased in animals receiving LV.PD-L1 transduced corneas compared to animals grafted with LV.eGFP transduced corneas. Moreover, reduced expression of proinflammatory cytokines (IFN-γ and IL-6) in PD-L1 transduced corneas compared to allogeneic controls was also observed. Local PD-L1 gene transfer in cultured corneas is a promising approach for the prolongation of corneal allograft survival and attenuation of graft rejection. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22300371     DOI: 10.1111/j.1600-6143.2011.03948.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  14 in total

1.  Update on the Management of High-Risk Penetrating Keratoplasty.

Authors:  Sayena Jabbehdari; Alireza Baradaran Rafii; Ghasem Yazdanpanah; Pedram Hamrah; Edward J Holland; Ali R Djalilian
Journal:  Curr Ophthalmol Rep       Date:  2017-02-02

2.  Correlation between human tear cytokine levels and cellular corneal changes in patients with bacterial keratitis by in vivo confocal microscopy.

Authors:  Takefumi Yamaguchi; Bernardo M Calvacanti; Andrea Cruzat; Yureeda Qazi; Shizu Ishikawa; Akinori Osuka; James Lederer; Pedram Hamrah
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-16       Impact factor: 4.799

3.  Donor bone marrow-derived dendritic cells prolong corneal allograft survival and promote an intragraft immunoregulatory milieu.

Authors:  Lisa O'Flynn; Oliver Treacy; Aideen E Ryan; Maurice Morcos; Marese Cregg; Jared Gerlach; Lokesh Joshi; Mikhail Nosov; Thomas Ritter
Journal:  Mol Ther       Date:  2013-07-18       Impact factor: 11.454

Review 4.  Bilateral Alterations in Corneal Nerves, Dendritic Cells, and Tear Cytokine Levels in Ocular Surface Disease.

Authors:  Takefumi Yamaguchi; Pedram Hamrah; Jun Shimazaki
Journal:  Cornea       Date:  2016-11       Impact factor: 2.651

Review 5.  Gene therapy in corneal transplantation.

Authors:  Yureeda Qazi; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

Review 6.  Gene Therapy in the Anterior Eye Segment.

Authors:  Cynthia Amador; Ruchi Shah; Sean Ghiam; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Curr Gene Ther       Date:  2022       Impact factor: 4.391

7.  Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis.

Authors:  Na Li; Wenwen Xu; Ying Yuan; Natarajan Ayithan; Yasutomo Imai; Xuesong Wu; Halli Miller; Michael Olson; Yunfeng Feng; Yina H Huang; Mary Jo Turk; Samuel T Hwang; Subramaniam Malarkannan; Li Wang
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

Review 8.  Strategies for local gene therapy of corneal allograft rejection.

Authors:  Pho Nguyen; Samuel C Yiu
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar

9.  Targeting herpetic keratitis by gene therapy.

Authors:  Hossein Mostafa Elbadawy; Marine Gailledrat; Carole Desseaux; Diego Ponzin; Stefano Ferrari
Journal:  J Ophthalmol       Date:  2012-12-26       Impact factor: 1.909

10.  A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells.

Authors:  Pratik Saxena; Boon Chin Heng; Peng Bai; Marc Folcher; Henryk Zulewski; Martin Fussenegger
Journal:  Nat Commun       Date:  2016-04-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.